3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia
3
Recurrence
2
Lymphoproliferative Disorders
2
Burkitt Lymphoma
2
Neoplasms
1
Neoplasm, Residual
1
Lymphatic Diseases
1
Immunoproliferative Disorders
1
Interventions
nilotinib
6
bosutinib
4
asciminib
3
Imatinib Mesylate
3
Dasatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
blinatumomab
×
Clear all
No trials found.